Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
CNN citing sources: Talks between Washington and Tehran are close to reaching a comprehensive agreement that could be concluded during the next meeting.
US Secretary of State: Washington will begin revoking visas for Chinese students affiliated with the Communist Party or studying in sensitive fields.
Israeli media: Western diplomats: There is a possibility that the US administration will sign an interim agreement or understanding with Iran.
Hamas: We affirm that we are making great efforts to stop the barbaric war on the Gaza Strip.
Hamas: We reached an agreement with Witkoff that includes the flow of aid and a professional committee taking over the management of the Gaza Strip's affairs immediately after the deal is announced.
Hamas: The agreement with Witkoff includes the release of 10 Israeli prisoners and bodies in exchange for the release of a number of Palestinian prisoners.
Hamas: We agreed with Witkoff on a general framework that would achieve a permanent ceasefire and a complete withdrawal of the occupation from Gaza.
Hamas: We have agreed to the framework of Witkoff's proposal and are awaiting the final response.
Al Mayadeen's correspondent in South Lebanon: Incident escalated to point where UNIFIL soldiers drew their weapons before Army intervened to calm matters down.
Al Mayadeen's correspondent in South Lebanon: Altercation breaks out between people of Yater in South and UNIFIL forces after latter entered town without an accompanying Lebanese Army patrol.

Cheaper TB drugs for millions after global deal on patent rights

  • By Al Mayadeen English
  • Source: News websites
  • 18 Jul 2023 11:34
3 Min Read

Pharmaceutical giant Johnson & Johnson to allow generic versions of its TB drug to be supplied to low-income countries.

  • x
  • A tuberculosis patient is given medication at an Operation ASHA program center in New Delhi, India. (AP)
    A tuberculosis patient is given medication at an Operation ASHA program center in New Delhi, India. (AP)

Johnson & Johnson has agreed to enable generic copies of their tuberculosis drug to be provided to low-income countries, but the agreement has been criticized for not going far enough to eliminate the company's stranglehold on worldwide Bedaquiline supplies.

The drug's global patent expires on Tuesday, July 18, but Johnson & Johnson is maintaining market dominance in countries through secondary patents that include some adjustments to a product to extend a patent. Due to J&J's decision, the Stop TB Partnership coalition is expected to be able to procure and distribute generic Bedaquiline through its Global Drug Facility (GDF) to 44 low- and middle-income countries.

The MSF Access Campaign applauded the decision, but argued that it was merely a "stopgap" measure and that the deal's terms needed to be made public. "We remain concerned that J&J retains the global authority to determine access to lifesaving generic versions of Bedaquiline in countries with a high burden of TB, even after the expiration of the main patent,” said Christophe Perrin, TB advocacy pharmacist for MSF Access Campaign.

J&J’s Bedaquiline, according to MSF Access, is the most expensive component of the multi-drug regimen for people with drug-resistant TB, but this could be reduced from $1.50 (£1.15) a day to $0.50.

The corporation should not enforce its existing secondary patents and should withdraw any ongoing applications for additional ones, according to Perrin, but if that's not the case, governments are expected to override patents and purchase the medication from generic manufacturers.

Related News

Johnson & Johnson investigated in South Africa for high TB drug price

Tuberculosis deaths on the rise in Europe, WHO warns

Read next: How is the door open for cheaper tuberculosis drugs in India?

“Only by taking these actions will J&J truly demonstrate a commitment to improving global access to Bedaquiline and prioritizing the health needs of people most affected by this deadly disease over profits accrued through secondary patents.”

In a statement, the Treatment Action Group (TAG) said the deal "falls short" of demands by TB patients and that it was using "patent evergreening... to extend monopoly rights over publically funded innovation," adding that J&J is avoiding accountability for the harm done on people with TB and the ones taken advantage of, along with those who have purchased Bedaquiline at unjustifiably high prices.

The CEO of GDF, Brenda Waning, stated that the agreement will allow them to offer generic Bedaquiline to low - and middle-income nations, even if secondary patents are in effect, adding that the company considers that countries could be supplied, regardless of patents. 

Patent money is used to fund the development of additional pharmaceuticals, according to a J&J representative, which generic producers do not typically do. 

The J&J spokesperson added, “More and faster innovation is needed, and IP [intellectual property] protections make it possible for companies to make the sustained financial commitments to discover and develop new and improved medicines needed to end diseases like TB that primarily affect people in low- and middle-income countries and protect the effectiveness of existing ones.”

  • Tuberculosis
  • Global Drug Facility
  • Bedaquiline
  • Johnson & Johnson

Most Read

US judges quietly consider private security amid Trump tensions

US judges quietly consider private security amid Trump pressures

  • US & Canada
  • 25 May 2025
Rep. Randy Fine, R-Palm Bay, answers a question about his House Bill 3-C: Independent Special Districts in the House of Representatives April 20, 2022, at the Capitol in Tallahassee, Florida (AP/Phil Sears)

GOP lawmaker says Gaza needs same end as WWII Japan, with nukes

  • MENA
  • 23 May 2025
President Donald Trump and Israeli Prime Minister Benjamin Netanyahu arrive to a news conference in the East Room of the White House, Tuesday, Feb. 4, 2025, in Washington (AP)

Rift widens: Trump, Netanyahu clash in heated phone call over Iran

  • Politics
  • 26 May 2025
Iran advisor reveals details of US-Iran nuclear talks to Al Mayadeen

Iran advisor reveals details of US-Iran nuclear talks: Al Mayadeen

  • MENA
  • 24 May 2025

Coverage

All
War on Gaza

Read Next

All
Israeli forces operate in a buffer zone in southern Lebanon as seen from northern occupied Palestine, Tuesday, February 18, 2025 (AP)
Politics

Israeli troops breach Lebanese territory, enter country's south

Chief of Iran's paramilitary Revolutionary Guard Gen. Hossein Salami speaks in a ceremony commemorating late Iranian President Ebrahim Raisi, the country's foreign minister and several other officials, in Tehran, Iran, Thursday, May 15, 2025 (AP)
Politics

IRGC commander warns Iran would 'open gates of hell' on 'Israel'

(Iran Foreign Ministry)
Politics

Iran denies reported enrichment freeze, reaffirms nuclear policy

President Donald Trump, right, listens as White House special envoy Steve Witkoff, left, speaks during a swearing in ceremony for interim U.S. Attorney General for the District of Columbia Jeanine Pirro, Wednesday, May 28, 2025 (AP)
Politics

Trump warns Netanyahu on Iran talks, pushes Gaza ceasefire plan

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS